Cargando…

Role of Probiotics in Helicobacter pylori Eradication: Lessons from a Study of Lactobacillus reuteri Strains DSM 17938 and ATCC PTA 6475 (Gastrus®) and a Proton-Pump Inhibitor

BACKGROUND: Meta-analyses involving >4000 subjects with probiotics added to antimicrobial Helicobacter pylori eradication therapy have reported a mean increase in the eradication rate of 12 to 14%. It is unclear how to translate that result into clinical practice. AIM: To evaluate whether adminis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dore, Maria Pina, Bibbò, Stefano, Pes, Giovanni Mario, Francavilla, Ruggero, Graham, David Y.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2019
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6466906/ https://www.ncbi.nlm.nih.gov/pubmed/31065301 http://dx.doi.org/10.1155/2019/3409820

Ejemplares similares

Lactobacillus reuteri DSM 17938 and ATCC PTA 5289 ameliorates chemotherapy-induced oral mucositis
por: Gupta, Nitasha, et al.
Publicado: (2020)

Effect of drops containing Lactobacillus reuteri (DSM 17938 and ATCC PTA 5289) on plaque acidogenicity and other caries-related variables in orthodontic patients
por: Alforaidi, Sahal, et al.
Publicado: (2021)

The use of Lactobacillus reuteri DSM 17938 and ATCC PTA 5289 on oral health indexes in a school population: A pilot randomized clinical trial
por: Borrell García, Carla, et al.
Publicado: (2021)

One-year supplementation with Lactobacillus reuteri ATCC PTA 6475 counteracts a degradation of gut microbiota in older women with low bone mineral density
por: Li, Peishun, et al.
Publicado: (2022)

Oral Microbiota Shift after 12-Week Supplementation with Lactobacillus reuteri DSM 17938 and PTA 5289; A Randomized Control Trial
por: Romani Vestman, Nelly, et al.
Publicado: (2015)

Orodispersible lozenges containing a combination of Lactobacillus reuteri DSM 17938 and Lactobacillus reuteri ATCC PTA 5289 and normal gum function: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006
por: Turck, Dominique, et al.
Publicado: (2020)

Lactobacillus reuteri DSM 17938 Improves Feeding Intolerance in Preterm Infants
por: Kaban, Risma K., et al.
Publicado: (2019)

Lactobacillus Reuteri DSM 17938 (Limosilactobacillus reuteri) in Diarrhea and Constipation: Two Sides of the Same Coin?
por: Saviano, Angela, et al.
Publicado: (2021)

Detection and Physicochemical Characterization of Membrane Vesicles (MVs) of Lactobacillus reuteri DSM 17938
por: Grande, Rossella, et al.
Publicado: (2017)

The efficacy of Lactobacillus reuteri DSM 17938 in infants and children: a review of the current evidence
por: Urbańska, Magdalena, et al.
Publicado: (2014)

Human Skin Bacterial Community Response to Probiotic (Lactobacillus reuteri DSM 17938) Introduction
por: Frerejacques, Marie, et al.
Publicado: (2020)

Efficacy of Lactobacillus reuteri DSM 17938 for infantile colic: Systematic review with network meta-analysis
por: Gutiérrez-Castrellón, Pedro, et al.
Publicado: (2017)

Impact of the fermentation parameters pH and temperature on stress resilience of Lactobacillus reuteri DSM 17938
por: Hernández, Armando, et al.
Publicado: (2019)

The role of Lactobacillus reuteri DSM 17938 for the absorption of iron preparations in children with iron deficiency anemia
por: Manoppo, Jeanette, et al.
Publicado: (2019)

Lactobacillus reuteri DSM 17938 for managing infant colic: protocol for an individual participant data meta-analysis
por: Sung, Valerie, et al.
Publicado: (2014)

Efficacy of Lactobacillus reuteri DSM 17938 for infantile colic: Systematic review with network meta-analysis: Erratum
Publicado: (2018)

Human Breast Milk Promotes the Secretion of Potentially Beneficial Metabolites by Probiotic Lactobacillus reuteri DSM 17938
por: Mai, Tu T., et al.
Publicado: (2019)

Systematic Review with Meta-Analysis: Lactobacillus reuteri DSM 17938 for Treating Acute Gastroenteritis in Children. An Update
por: Patro-Gołąb, Bernadeta, et al.
Publicado: (2019)

Microvesicles from Lactobacillus reuteri (DSM-17938) completely reproduce modulation of gut motility by bacteria in mice
por: West, Christine L., et al.
Publicado: (2020)

Effects of Lactobacillus reuteri DSM 17938 in preterm infants: a double-blinded randomized controlled study
por: Cui, Xuewei, et al.
Publicado: (2019)

Effect of a Partially Hydrolysed Whey Infant Formula Supplemented with Starch and Lactobacillus reuteri DSM 17938 on Regurgitation and Gastric Motility
por: Indrio, Flavia, et al.
Publicado: (2017)

Beneficial effects of Lactobacillus reuteri 6475 on bone density in male mice is dependent on lymphocytes
por: Collins, Fraser L., et al.
Publicado: (2019)

Lactobacillus reuteri DSM 17938 in the prevention of antibiotic-associated diarrhoea in children: protocol of a randomised controlled trial
por: Kołodziej, Maciej, et al.
Publicado: (2017)

Efficacy of Lactobacillus Reuteri DSM 17938 for the Treatment of Acute Gastroenteritis in Children: Protocol of a Randomized Controlled Trial
por: Szymański, Henryk, et al.
Publicado: (2017)

Human Breast Milk Promotes the Immunomodulatory Function of Probiotic Lactobacillus reuteri DSM 17938 in the Neonatal Rat Intestine
por: Hoang, Thomas K, et al.
Publicado: (2019)

Lactobacillus reuteri 6475 Increases Bone Density in Intact Females Only under an Inflammatory Setting
por: Collins, Fraser L., et al.
Publicado: (2016)

Characterizing how probiotic Lactobacillus reuteri 6475 and lactobacillic acid mediate suppression of osteoclast differentiation
por: Quach, Darin, et al.
Publicado: (2019)

Genomic, phenotypic, and clinical safety of Limosilactobacillus reuteri ATCC PTA 4659
por: Sendelius, Malin, et al.
Publicado: (2023)

In silico, in vitro and in vivo safety evaluation of Limosilactobacillus reuteri strains ATCC PTA-126787 & ATCC PTA-126788 for potential probiotic applications
por: Gangaiah, Dharanesh, et al.
Publicado: (2022)

Lactobacillus reuteri DSM 17938 Probiotics May Increase CC-Chemokine Receptor 7 Expression in Infants Treated With for Colic
por: Savino, Francesco, et al.
Publicado: (2019)

Safety and Tolerability of Lactobacillus reuteri DSM 17938 and Effects on Biomarkers in Healthy Adults: Results from a Randomized Masked Trial
por: Mangalat, Nisha, et al.
Publicado: (2012)

The Efficacy and Safety of the Probiotic Bacterium Lactobacillus reuteri DSM 17938 for Infantile Colic: A Meta-Analysis of Randomized Controlled Trials
por: Xu, Man, et al.
Publicado: (2015)

Correlation between the Antimicrobial Activity and Metabolic Profiles of Cell Free Supernatants and Membrane Vesicles Produced by Lactobacillus reuteri DSM 17938
por: Maccelli, Alessandro, et al.
Publicado: (2020)

Lactobacillus reuteri DSM 17938 and Magnesium Oxide in Children with Functional Chronic Constipation: A Double-Blind and Randomized Clinical Trial
por: Kubota, Megumi, et al.
Publicado: (2020)

A systematic review and meta-analysis: the therapeutic and preventive effect of Lactobacillus reuteri DSM 17,938 addition in children with diarrhea
por: Sun, Xiaoqi, et al.
Publicado: (2023)

454 Pyrosequencing Analysis on Faecal Samples from a Randomized DBPC Trial of Colicky Infants Treated with Lactobacillus reuteri DSM 17938
por: Roos, Stefan, et al.
Publicado: (2013)

Lactobacillus reuteri DSM 17938 Changes the Frequency of Foxp3(+) Regulatory T Cells in the Intestine and Mesenteric Lymph Node in Experimental Necrotizing Enterocolitis
por: Liu, Yuying, et al.
Publicado: (2013)

Lactobacillus reuteri DSM 17938 as a Novel Topical Cosmetic Ingredient: A Proof of Concept Clinical Study in Adults with Atopic Dermatitis
por: Butler, Éile, et al.
Publicado: (2020)

Inclusion of Lactobacillus Reuteri in the Treatment of Helicobacter pylori in Sardinian Patients: A Case Report Series
por: Dore, Maria P., et al.
Publicado: (2016)

Effect of routine probiotic, Lactobacillus reuteri DSM 17938, use on rates of necrotizing enterocolitis in neonates with birthweight < 1000 grams: a sequential analysis
por: Hunter, Chelsea, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_vhnkka0uil3id2cafudvq4qfc4